Stages of Liver Disease: From Inflammation to Failure

Liver disease progresses through four main stages: inflammation, fibrosis, cirrhosis, and liver failure. Each stage represents increasing damage to liver tissue, and the earlier you catch it, the better the chances of slowing or even reversing the harm. Many people move through the first two stages with no symptoms at all, which is why liver disease often goes undetected until significant damage has already occurred.

Stage 1: Inflammation

The earliest stage of liver disease is inflammation. This is your liver’s natural response to injury, whether from excess fat buildup, a viral infection like hepatitis B or C, heavy alcohol use, or metabolic conditions like type 2 diabetes and obesity. The liver becomes swollen and irritated as it tries to fight off whatever is causing damage.

Most people at this stage have no obvious symptoms. Some notice tenderness or a dull ache on the right side of the abdomen, just below the ribs. Routine blood tests may reveal elevated liver enzymes (ALT and AST), which signal that liver cells are being damaged. Normal ALT runs between 7 and 55 units per liter, and AST between 8 and 48. Values above those ranges can be an early flag, though they don’t tell you how far the disease has progressed.

The good news: inflammation at this stage is fully reversible. If the underlying cause is addressed, whether that means treating a hepatitis infection, reducing alcohol intake, or managing weight and blood sugar, the liver can heal itself completely.

Stage 2: Fibrosis

When inflammation persists without treatment, the liver begins to form scar tissue. This scarring is called fibrosis, and it replaces healthy liver tissue over time. Think of it like a wound that keeps reopening before it can heal properly. Each cycle of injury and repair leaves behind a little more scar tissue, and the liver gradually becomes stiffer and less efficient.

Fibrosis is graded on a scale from F0 (no scarring) to F4 (cirrhosis) using biopsy results or specialized imaging. At F1 through F3, scar tissue is limited to specific areas within the liver, and blood flow through the organ remains relatively normal. People at these stages typically feel fine, which makes fibrosis easy to miss without testing.

Mild to moderate fibrosis (F1 through F3) is reversible. Studies using repeat biopsies have confirmed that when the source of damage is eliminated, such as clearing a hepatitis C infection with antiviral treatment, the scarring visible on the first biopsy can disappear entirely on follow-up. The critical detail is timing: the longer fibrosis goes untreated, the more cross-linked and permanent the scar tissue becomes.

Stage 3: Cirrhosis

Cirrhosis means the scarring has become widespread and the liver’s internal structure is significantly distorted. At this point, healthy tissue has been replaced by bands of scar tissue that block normal blood flow through the organ. Cirrhosis sits at F4 on the fibrosis scale and marks a turning point in the disease: while some improvement is possible, the liver cannot fully return to normal.

Cirrhosis itself has two very different phases, and the distinction between them is one of the most important things to understand about liver disease.

Compensated Cirrhosis

In the early phase, called compensated cirrhosis, the liver is scarred but still functioning well enough to do its job. Many people at this stage have no symptoms at all, or only mild ones like fatigue. The liver has remarkable reserve capacity, and even with significant scarring, it can continue filtering blood, producing proteins, and processing nutrients. Median survival with compensated cirrhosis is roughly 10 to 12 years, and many people live much longer with proper management.

Decompensated Cirrhosis

Each year, about 5% to 7% of people with compensated cirrhosis cross into decompensation. This is when the liver can no longer keep up, and serious complications appear. The hallmarks of decompensated cirrhosis include:

  • Ascites: fluid accumulation in the abdomen, which can become infected and life-threatening
  • Variceal bleeding: swollen blood vessels in the esophagus or stomach that can rupture, causing vomiting of blood or black, tarry stools
  • Hepatic encephalopathy: confusion, personality changes, and in severe cases coma, caused by toxins building up in the blood that the liver can no longer filter
  • Kidney impairment: the failing liver disrupts blood flow to the kidneys, potentially causing them to shut down as well

Median survival drops sharply once decompensation occurs, falling to roughly 1 to 2 years without a transplant. The one-year mortality rate climbs from about 1% in early compensated cirrhosis to approximately 57% in people who have experienced variceal bleeding.

Stage 4: End-Stage Liver Disease

End-stage liver disease (ESLD) is the final phase, where the liver has lost nearly all functional capacity. The complications of decompensated cirrhosis become more frequent and harder to manage. Organ systems beyond the liver start failing. The kidneys and lungs are particularly vulnerable, and infections become increasingly dangerous because the immune system depends on a working liver.

At this stage, a liver transplant is typically the only treatment that can extend life significantly. Priority for transplant is determined by the MELD score, a number ranging from 6 to 40 that’s calculated from blood test results. A higher score means a more urgent need. People with scores between 25 and 40 are rechecked every seven days because their condition can deteriorate quickly. The score formula was recently updated to give women additional points, because research showed that women were more likely to die on the waitlist due to differences in how certain lab values (particularly creatinine) reflect disease severity across sexes.

MELD scores can fluctuate in both directions while you wait. An improving score means the liver is stabilizing; a rising score means the need is becoming more critical.

What Drives Progression

The most common cause of liver disease worldwide is now metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease. It’s driven by obesity (especially abdominal fat), type 2 diabetes, insulin resistance, and high triglycerides. Excess fat accumulates in the liver, triggering the inflammation that starts the whole cascade.

Other major causes include chronic hepatitis B and C infections, heavy alcohol use over many years, autoimmune conditions where the immune system attacks liver tissue, and certain genetic disorders that cause iron or copper to build up in the organ. In many cases, more than one factor is at work simultaneously, which accelerates the timeline from inflammation to cirrhosis.

When Damage Can Still Be Reversed

The liver is one of the few organs that can regenerate, but that ability has limits. Inflammation and mild to moderate fibrosis (stages 1 and 2) are clearly reversible when the underlying cause is removed. Once cirrhosis develops, the extensive cross-linking of scar tissue creates a structural change that the liver cannot fully undo, though some regression of scarring is possible even at this stage if the cause of injury is eliminated.

This is why early detection matters so much. Most liver damage accumulates silently over years or decades. By the time symptoms like jaundice, abdominal swelling, or confusion appear, the disease has usually reached cirrhosis or beyond. Routine blood work that includes liver enzymes, combined with awareness of risk factors like obesity, diabetes, or heavy drinking, is the most practical way to catch liver disease while it’s still in a stage where full recovery is possible.